Wanle Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wanle Hu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Kepeng Hu
Department of Coloproctology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
3 shared publicationsRongjiao Sun
Department of Thyroid and Breast Surgery, General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, PR China
3 shared publications- Ying Tan
Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325000, China
3 shared publications Changjia Li
Qingdao Municipal Hospital Group
2 shared publicationsChenchen Wu
Wenzhou Medical University
2 shared publicationsChongjie Huang
Wenzhou Medical College Second Affiliated Hospital: Wenzhou Medical University Second Affiliated Hospital
2 shared publications
Latest Publications
- 19 February 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 351, 151026
Engineering carboxymethyl chitosan/dialdehyde starch hydrogel as a therapeutic platform for immuno-microbial modulation in ulcerative colitis
- 19 February 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 351, 151026
Engineering carboxymethyl chitosan/dialdehyde starch hydrogel as a therapeutic platform for immuno-microbial modulation in ulcerative colitis
- 5 February 2025
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 27 (11) , 2823-2845
Biodegradable microbeads for personal care products and cosmetics
The materials, preparation methods, properties, and applications of biodegradable microbeads in personal care products and cosmetics.
- 5 February 2025
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 27 (11) , 2823-2845
Biodegradable microbeads for personal care products and cosmetics
The materials, preparation methods, properties, and applications of biodegradable microbeads in personal care products and cosmetics.
- 16 November 2022
- Published by Elsevier in Carbohydrate Polymers
- Vol. 301 (Pt B) , 120348
Injectable carboxymethyl chitosan-genipin hydrogels encapsulating tea tree oil for wound healing
- 16 November 2022
- Published by Elsevier in Carbohydrate Polymers
- Vol. 301 (Pt B) , 120348
Injectable carboxymethyl chitosan-genipin hydrogels encapsulating tea tree oil for wound healing
- Open Access
- 15 October 2020
- Published by Springer Nature in Research Square
CpG Island Methylator Phenotype(CIMP) is An Independent Prognostic Marker with Tumor-Promoting Functions in Colorectal Cancer
Background: The CpG island methylator phenotype(CIMP)with extensive promoter methylation isa distinct epigenotype incolorectal cancer (CRC). Changes in microbiota and epigenetic dysregulation might be the key underlying mechanism.Methods: Tissues with stages I–III cancer were collected after proctocolectomy. The 16S rRNA gene sequencing was carried to determine the differences in microbiota. Subsequently, BRAF mutation, the status of microsatellite instability (MSI, also known as mismatch repair deficiency) and CIMP were also tested. The Chi-square test was carried out to analyze the relationship between molecular changes (MSI and CIMP) and the development of CRC.Results: Patients in the three groups differed in thetumorlocation(P=0.034) and the carcinoembryonic antigen (CEA) level (P=0.036).The positive CIMP and MSI-LOW/MSS were more common in the worse prognosis groups. The Kaplan–Meier and Cox proportional regression analyses indicated that CIMP and MSI were the independent indicators of poor survival since the positive rates of which were significantly higher in the non-survival group. Besides, there were differences in microbiota among tumor tissues of different prognoses, with the Fusobacterium nucleatum and Bacteroides fragilis more abundant in the worse prognosis groups.Conclusion: The persistent epigenetic changes influence the prognosis of patients with CRC and the composition of the gut microbiota might be the cause.
- 15 October 2020
- Published by Springer Nature in Research Square
Open AccessCpG Island Methylator Phenotype(CIMP) is An Independent Prognostic Marker with Tumor-Promoting Functions in Colorectal Cancer
Background: The CpG island methylator phenotype(CIMP)with extensive promoter methylation isa distinct epigenotype incolorectal cancer (CRC). Changes in microbiota and epigenetic dysregulation might be the key underlying mechanism.Methods: Tissues with stages I–III cancer were collected after proctocolectomy. The 16S rRNA gene sequencing was carried to determine the differences in microbiota. Subsequently, BRAF mutation, the status of microsatellite instability (MSI, also known as mismatch repair deficiency) and CIMP were also tested. The Chi-square test was carried out to analyze the relationship between molecular changes (MSI and CIMP) and the development of CRC.Results: Patients in the three groups differed in thetumorlocation(P=0.034) and the carcinoembryonic antigen (CEA) level (P=0.036).The positive CIMP and MSI-LOW/MSS were more common in the worse prognosis groups. The Kaplan–Meier and Cox proportional regression analyses indicated that CIMP and MSI were the independent indicators of poor survival since the positive rates of which were significantly higher in the non-survival group. Besides, there were differences in microbiota among tumor tissues of different prognoses, with the Fusobacterium nucleatum and Bacteroides fragilis more abundant in the worse prognosis groups.Conclusion: The persistent epigenetic changes influence the prognosis of patients with CRC and the composition of the gut microbiota might be the cause.
- Open Access
- 24 September 2020
- Published by Springer Nature in Research Square
CpG Island Methylator Phenotype(CIMP) is An Independent Prognostic Marker with Tumor-Promoting Functions in Colorectal Cancer
BackgroundThe CpG island methylator phenotype(CIMP)with extensive promoter methylation isa distinct epigenotype incolorectal cancer (CRC). Changes in microbiota and epigenetic dysregulation mightbe the key underlying mechanism.MethodsTissueswith stages I–III cancerwere collected afterproctocolectomy. The 16S rRNA gene sequencing was carried to determine the differences in microbiota.Subsequently,BRAF mutation,the statusof microsatellite instability (MSI, also known as mismatch repair deficiency) and CIMP were also tested. The Chi-square test was carriedoutto analyze the relationship between molecular changes (MSI and CIMP) and the development of CRC.ResultsPatients in the three groups differed in thetumorlocation(P=0.034) and the carcinoembryonic antigen (CEA) level (P=0.036).The positive CIMP and MSI-LOW/MSS were more common in the worse prognosis groups.The Kaplan–Meier and Cox proportional regression analyses indicated that CIMP and MSI were the independent indicators of poor survival since the positive rates of which were significantly higher in the non-survival group. Besides, there were differences in microbiota among tumor tissues of different prognoses, with the Fusobacterium nucleatum and Bacteroides fragilis more abundant in the worse prognosis groups.ConclusionThe persistent epigenetic changes influence the prognosis of patients with CRC and the composition of the gut microbiota might be the cause.
- 24 September 2020
- Published by Springer Nature in Research Square
Open AccessCpG Island Methylator Phenotype(CIMP) is An Independent Prognostic Marker with Tumor-Promoting Functions in Colorectal Cancer
BackgroundThe CpG island methylator phenotype(CIMP)with extensive promoter methylation isa distinct epigenotype incolorectal cancer (CRC). Changes in microbiota and epigenetic dysregulation mightbe the key underlying mechanism.MethodsTissueswith stages I–III cancerwere collected afterproctocolectomy. The 16S rRNA gene sequencing was carried to determine the differences in microbiota.Subsequently,BRAF mutation,the statusof microsatellite instability (MSI, also known as mismatch repair deficiency) and CIMP were also tested. The Chi-square test was carriedoutto analyze the relationship between molecular changes (MSI and CIMP) and the development of CRC.ResultsPatients in the three groups differed in thetumorlocation(P=0.034) and the carcinoembryonic antigen (CEA) level (P=0.036).The positive CIMP and MSI-LOW/MSS were more common in the worse prognosis groups.The Kaplan–Meier and Cox proportional regression analyses indicated that CIMP and MSI were the independent indicators of poor survival since the positive rates of which were significantly higher in the non-survival group. Besides, there were differences in microbiota among tumor tissues of different prognoses, with the Fusobacterium nucleatum and Bacteroides fragilis more abundant in the worse prognosis groups.ConclusionThe persistent epigenetic changes influence the prognosis of patients with CRC and the composition of the gut microbiota might be the cause.